Advertisement
Advertisement
XBIT
XBiotech Inc
6.39
USD-0.35
-5.19%
Dec 18, 14:39 UTC -5
Open
XBiotech Inc Profile
About
Info & Links
CEO
John Simard
Headquarters
AUSTIN, TX 78744, UNITED STATES
Industry
Sector
Website
Auditor
Whitley Penn LLP
Share holders
11
Employees
82
XBiotech Inc Statistics
Valuation Measures
Market Capitalization2
194.77M
Enterprise Value
21.65M
Enterprise Value/EBITDA(ttm)
-0.53
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
1.10
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-15.99%
Return on Invested Capital(ttm)
-16.12%
Return on Assets(ttm)
-14.85%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-40.57M
Net Income Available to Common(ttm)
-32.66M
Diluted EPS(ttm)
-1.08
Share Statistics
Beta (5Y Monthly)
1.41
52-Week Change
62.60%
S&P 500 52-Week Change
26.15%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
30.48M
Dividend Yield
0.00%
Float4
20.39M
% Held by Insiders
33.10%
% Held by Institutions
55.70%
Balance Sheet
Total Cash(mrq)
183.12M
Total Cash Per Share(mrq)
6.01
Total Debt(mrq)
10.00M
Total Debt/Equity(mrq)
5.21%
Current Ratio(mrq)
11.57%
Quick Ratio(mrq)
11.57%
Book Value Per Share(mrq)
6.30
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.80
Free Cash Flow(ytd)
-25.64M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement